Bacterial infections continue to pose a major global public health challenge, a situation compounded by the rise of antimicrobial resistance. Recent attention has focused on outer membrane vesicles (OMVs) produced by Gram-negative bacteria because of their multifaceted roles in host-pathogen interactions. The reviewed work synthesizes current understanding of how OMVs contribute to immune evasion and persistent infection, and it discusses strategies being explored to counteract OMV-mediated effects.
OMVs are nanoscale, membrane-derived particles shed from the outer membrane of Gram-negative bacteria. They encapsulate a variety of components derived from the parent bacterium, including proteins, lipids, nucleic acids and other virulence-associated molecules. Because OMVs carry biologically active cargo and can interact with host cells at a distance from the parent bacterium, they function as delivery vehicles to modulate host responses during infection.
The evidence reviewed indicates that OMVs promote immune evasion through multiple, sometimes overlapping mechanisms. The review emphasizes several functional pathways by which OMVs influence host immunity: repression of host immune gene expression, reprogramming of intracellular signaling that controls cell survival and death, facilitation of bacterial entry and persistence within host cells, enhancement of biofilm formation, modulation of inflammatory and tolerance pathways, neutralization of host immune effectors, and induction of epigenetic changes in host cells.
OMVs have been implicated in downregulating host immune gene expression. By delivering regulatory molecules to host cells, OMVs can suppress transcriptional programs required for effective immune detection and clearance. The review notes this as a critical mechanism by which bacteria reduce the host’s ability to mount timely and robust antimicrobial responses, although detailed molecular targets and pathways were not enumerated in the abstract.
Another mechanism described is modulation of host cell survival and signaling pathways. OMV cargo can influence intracellular signaling cascades that determine cell fate and immune activation, enabling bacteria to alter apoptosis, inflammatory signaling, or other processes relevant to pathogen containment. The precise signaling nodes affected and the downstream consequences are presented as areas of active investigation.
OMVs facilitate bacterial colonization within host cells, either by priming host cells for uptake or by delivering effectors that promote intracellular survival. This intracellular niche provides bacteria with a protected environment that shields them from extracellular immune effectors and certain antibiotics, contributing to persistence and chronic infection.
The review highlights a role for OMVs in promoting biofilm formation and maturation. Biofilms provide a structured community and extracellular matrix that protect microbes from host defenses and antimicrobial agents. Through delivery of matrix components or signaling molecules, OMVs can enhance biofilm development and thereby support long-term colonization.
OMVs are reported to influence the balance between proinflammatory responses and immune tolerance. By dampening inflammation in some contexts or inducing regulatory pathways in others, OMVs can reduce immune-mediated clearance and create a permissive environment for bacterial survival. The review underscores that OMV-driven modulation of inflammation is context-dependent and mechanistically complex.
OMVs can act as decoys or carriers that neutralize host immune effectors. For example, OMVs may bind or sequester antimicrobial peptides and other soluble defenses, reducing their effective concentrations at the site of infection. This neutralization contributes to bacterial resistance against innate immune mechanisms.
The authors discuss emerging evidence that OMVs can induce epigenetic changes in host cells. Such reprogramming has the potential to alter long-term gene expression patterns in immune cells or tissues, thereby influencing the trajectory of host responses beyond the acute phase of infection. Detailed molecular mechanisms and the functional consequences of OMV-induced epigenetic modifications are identified as incompletely characterized.
The review addresses current and emerging approaches aimed at mitigating OMV-mediated immune evasion. Although specific therapeutic modalities and experimental results are not described in the abstract, the authors indicate that targeting OMV production, release, cargo, or host interactions represents a promising direction for anti-infective research and therapeutic development. The review positions such strategies as potential adjuncts to conventional antimicrobial approaches, especially given the global challenge of antimicrobial resistance.
OMVs are versatile effectors that contribute to bacterial immune evasion via multiple mechanisms including gene silencing, signaling modulation, promotion of intracellular niches, enhancement of biofilm formation, modulation of inflammation and immune tolerance, neutralization of host factors, and epigenetic reprogramming. The mechanisms underlying many of these effects remain incompletely understood, and the review calls for further research to delineate molecular details and validate therapeutic targets. Advancing knowledge of OMV biology may guide development of novel interventions to limit bacterial persistence and improve outcomes in bacterial infections.
(Conflict of interest: the authors declared no competing interests. Funding and detailed experimental data and specific therapeutic strategies were discussed in the full article; these details were not reported in the abstract provided.)